Decode Age raises INR 14.48 crore in pre-Series A round

Decode Age, a longevity science startup, has raised INR 14.48 crore in its pre-Series A funding round led by Dr Krishna Prasad Chigurupati (Chairman and Managing Director, Granules India).

The new funds will be used to expand biomarker discovery programs, advance multi-omics and microbiome research and improve scientific and analytical infrastructure. They will also support research on ageing, focusing on cellular energy, metabolism, inflammation and cognitive health, while fostering stronger collaboration within the longevity ecosystem.

Read also- AI marketing firm MoEngage raises additional $180 Mn in Series F round

Parth Amin, CEO and Co-founder, Decode Age, said, “This investment marks an important step forward in our mission to bring scientific precision to the way people understand their biology. The support from Dr Chigurupati strengthens our ability to advance ageing and gut microbiome research, expand our biomarker programmes and build the scientific infrastructure that drives our work. We are grateful for his belief in our vision and remain committed to translating rigorous science into insights that help individuals make informed decisions about their long-term health.”

Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India, said, “Decode Age is advancing an area of science that will redefine how we think about health, disease and ageing. Their capabilities in gut microbiome research and ageing biology are rigorous and forward-looking, offering for individuals and clinicians biological insights that were previously inaccessible. This investment reflects my confidence in their scientific vision and the longterm impact they aim to create.”

About Decode Age

Founded in 2021 by Parth Amin, Darshit Patel, and Rakesh Somani, Decode Age is a longevity science organization focused on ageing biology, biomarker research, and gut microbiome science. It has built a comprehensive research platform covering multi-omics testing, biomarker discovery and precision-based interventions.

The company aims to position India as a leader in microbiome science and healthy ageing research, creating solutions that meet global standards of scientific rigour, quality, and practical value.

Advertisment

Decode Age collaborates with institutions such as the Indian Institute of Science and global initiatives like XPRIZE, contributes to microbiome data generation, analysis and longevity medicine development.

Since its founding in 2021, Decode Age has established advanced metagenomics and microbiome laboratories, introduced whole-genome microbiome analysis for individuals and developed precision formulations informed by ageing biology and microbiome science.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Latest Business and Startup News: Discover Funding Trends and Stories Shaping Indian Startups.

Startup Funding News: Your Gateway to Every Funding Update.

Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Startup Stories: Discover inspiring tales of startups overcoming challenges, and achieving success.

Advertisment